Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation

Published:2014-11-05 Issue:5 Volume:29 Page:1143-1152
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Crucitti L,Crocchiolo R,Toffalori C,Mazzi B,Greco R,Signori A,Sizzano F,Chiesa L,Zino E,Lupo Stanghellini M T,Assanelli A,Carrabba M G,Marktel S,Marcatti M,Bordignon C,Corti C,Bernardi M,Peccatori J,Bonini C,Fleischhauer K,Ciceri F,Vago L

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014314.pdf

Reference33 articles.

1. Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.

2. Estey E, Dohner H . Acute myeloid leukaemia. Lancet 2006; 368: 1894–1907.

3. Kolb HJ . Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008; 112: 4371–4383.

4. Pavletic SZ, Kumar S, Mohty M, de Lima M, Foran JM, Pasquini M et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation. Biol Blood Marrow Transplant 2010; 16: 871–890.

5. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091–2101.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical hematopoietic cell transplantation as a platform for natural killer cell immunotherapy;American Journal of Hematology;2024-09-09

2. Tricking the trickster: precision medicine approaches to counteract leukemia immune escape after transplant;Blood;2024-06-27

3. Pretransplantation risk factors for MRD after allogeneic stem cell transplantation in AML patients: A prospective study;2024-06-07

4. Single-cell analysis of the survival mechanisms of fratricidal CAR-T targeting of T cell malignancies;Molecular Therapy - Nucleic Acids;2024-06

5. Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients;Blood Cancer Journal;2024-05-02